Minaxi P. Jhawer, MD

  • Hematology
  • Oncology

I strongly believe empowering my patients and their family with the knowledge of their diagnosis and treatment options is integral to their care. I strive to personalize and individualize the treatment options for each patient.

Languages Spoken

  • Hindi
  • Gujrati

Related Practices

  • Hematology/Oncology Physicians of Englewood

Specialties, Procedures &
Conditions Treated

Primary Areas of Practice

  • Hematology
  • Oncology

Other Areas of Practice

  • Bloodless Medicine
  • Cancer Prevention
  • Integrative Medicine
  • Palliative Care

Procedures

  • Cancer Pain Management
  • Chemotherapy
  • Immunotherapy
  • Infusion Therapy
  • Intrathecal Therapy
  • Plasmapheresis and Exchange
  • Targeted Therapy

Conditions Treated

  • Anal Cancer
  • Appendix Cancer
  • Bile Duct Cancer
  • Cholangiocarcinoma
  • Colon Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Gallbladder Cancer
  • Gastroesophageal Junction (GEJ) Cancer
  • Gastrointestinal Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Peritoneal Cancer
  • Rectal Cancer
  • Stomach Cancer

Locations &
Appointments

Locations

  • Hematology Oncology Physicians of Englewood, PA

    350 Engle Street 6th Floor, Berrie Center Englewood, NJ 07631

    Main: 201-568-5250
    Fax: 201-568-5358

Insurance

Insurances Accepted

Below is a list of the insurance plans that your provider participates in. It is very important that you contact your insurance company prior to receiving services or care. Each health insurance plan is different and some provide different levels of coverage: only your health insurance plan can provide complete information regarding your coverage and potential out-of-pocket costs.

1199 (SEIU)

  • 1199 (SEIU)

Aetna

  • Aetna HMO
  • Aetna PPO
  • Aetna POS
  • Aetna Medicare Managed Care
  • Medsolutions
  • Meritan Health

Amerigroup

  • Amerivantage
  • Amerigroup Medicaid

AmeriHealth

  • AmeriHealth HMO
  • AmeriHealth PPO
  • Value Network (Exchange Plan)
  • AmeriHealth Administrator

APWU

  • APWU Health Plan

Cigna

  • Great-West Healthcare (GWH)
  • Cigna HMO
  • Cigna PPO
  • Cigna Supplemental
  • Health Partners

Clover Health

  • Clover Health

Consumer Health Network (CHN)

  • CHN PPO

CoreSource

  • CoreSource

Coventry

  • CCN

EmblemHealth

  • EmblemHealth EPO
  • EmblemHealth EPO2
  • EmblemHealth FEHB
  • EmblemHealth FEHBP
  • EmblemHealth GHI PPO
  • EmblemHealth GHI CBP
  • EmblemHealth National
  • EmblemHealth PPO1
  • EmblemHealth PPO2
  • EmblemHealth PPO3
  • EmblemHealth Tri-State
  • Vytra

Empire BCBS

  • Blue Access Network
  • Blue Priority
  • Direct HMO
  • Direct PPO
  • Empire BCBS EPO
  • Empire BCBS HMO
  • Empire BCBS POS
  • Empire BCBS PPO
  • Pathway EPO
  • Pathway HMO
  • Prism
  • Silver
  • Total Blue

Empire Plan (NYSHIP)

  • Empire Plan (NYSHIP)

First Health

  • First Health

Galaxy Health Network

  • Galaxy Health Network PPO

GEHA

  • GEHA Health Plan

Horizon BCBS

  • Federal Employee Program
  • Horizon BCBS EPO
  • Horizon BCBS HMO
  • Horizon BCBS Medicare Managed Care
  • Horizon BCBS PPO
  • OMNIA Tier 1
  • NJ Carpenters Fund
  • Traditional

Horizon NJ Health

  • Horizon NJ Health Medicaid

MagnaCare

  • Local 825
  • MagnaCare PPO

Mail Handlers

  • Mail Handlers Benefit Plan (MHBP)

Medicaid

  • Medicaid NJ

Medicare

  • Medicare NJ

MultiPlan/PHCS

  • Beech Street
  • MultiPlan Humana
  • PHCS
  • Pomco
  • MultiPlan Worker’s Comp

MVP Health Care

  • MVP Health Care PPO

NALC

  • NALC Health Benefit Plan

Nippon Life Insurance Co of America

  • Nippon Life Benefits

Oxford

  • Freedom
  • Garden State Network
  • Liberty
  • Metro
  • Oxford Medicare

QualCare

  • Choice Care
  • HIP HMO
  • HIP PPO
  • HIP PRIME HMO
  • HIP PRIME PPO
  • Oscar
  • QualCare EPO
  • QualCare FEHB
  • QualCare GHI PPO
  • QualCare HMO
  • QualCare Humana
  • QualCare PPO
  • QualCare Worker's Comp

Railroad Medicare

  • Railroad Medicare NJ

Transparent Health Network

  • Transparent Health Network

TRICARE North Region

  • DVA
  • CHAMPVA

UMR

  • UMR

UnitedHealthcare

  • AARP
  • Commercial and Marketplace
  • Compass Benefit (Exchange)
  • Medica
  • River Valley
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare StudentResources

United Healthcare Community and State

  • United Healthcare Community and State Medicare
  • United Healthcare Community and State Medicaid (NJ Family Care)
  • Dual Complete

Wellcare

  • Wellcare Medicaid Managed Care
  • Wellcare Medicare Managed Care

About

About Minaxi P. Jhawer

Dr. Jhawer is chief of hematology/oncology. She is board certified in internal medicine, medical oncology, and hematology and specializes in cancers of the esophagus, stomach, small bowel, liver and bile ducts (hepatobiliary tract), pancreas, colon, and rectum. Dr. Jhawer completed postdoctoral fellowship training at Johns Hopkins University. After her residency and fellowship at Albert Einstein College of Medicine, she served on the gastrointestinal medical oncology faculty at Memorial Sloan Kettering Cancer Center. She developed and co-led EHMC’s disease management team in gastroenterology and hepatobiliary cancer. She co-leads the multidisciplinary cancer conferences for patients diagnosed with GI cancer.

Dr. Jhawer collaborates with colleagues from New York City hospitals on caring for oncology patients and on clinical trials. She has been a principal investigator on many clinical trials and has presented her work at national conferences and been published in peer-reviewed journals. Dr. Jhawer is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research. She was recently appointed to the Clinical Practice Guidelines Committee of the American Society of Clinical Oncology. Dr. Jhawer is active in medical education and community outreach programs. She is involved in development of the survivorship plan, palliative care in the outpatient setting, and integrative medicine at Englewood Health's Graf Center for Integrative Medicine.

Honors & Awards

  • 2020, 2019, 2017: Bergen Magazine Top Doctors
  • 2020-2016: Castle Connolly Top Doctors New York Metro Area
  • 2019: Exceptional Women in Medicine
  • 2019-2017: Jersey's Best: Top Doctors for Cancer
  • 2019-2015: Jersey's Best Magazine Top Doctors
  • 2018, 2017, 2015: New York Magazine Best Doctors
  • 2018: New Jersey Monthly Magazine Top Doctor
  • 2017: Americas Most Honored Top 1% Professionals
  • 2015: Life and Living Show- Interview 5/20/15
  • 2015: 201 Magazine Top Doctors-Top 20 People to Watch in Health Care

Professional Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Medical Association
  • American Association for Cancer Research
  • Bergen Indian Medical Association

Committees and Leadership Positions

  • Section Chief, Hematology/Oncology
  • 2017 - 2020: Member, American Society of Clinical Oncology Clinical Practice Guidelines Committee
  • 2017: Elected to Medical Executive Committee
  • 2016 - present: Bylaws Committee
  • 2014 - present: Advisory Board for Integrative Medicine Department
  • 2014 - present: Medical Advisory Board for Kula for Karma
  • Co-Leader for Upper, Lower GI and Hepatobiliary Tumor Board and DMT
  • Established Funding for Complementary Yoga Program for Englewood Hospital Cancer Patients and Their Caregivers
  • Survivorship Program for Patients with Curable Cancers
  • Established Pain and Palliative Consultation and Care in the Outpatient Oncology Setting

Global Health and Community Health Activities

  • Korean /Asian population screening for GI cancers

Education &
Training

Education & Degrees

  • MD: Dr. D.Y. Patil Medical College

Residency

  • Albert Einstein College of Medicine - Jacobi Medical Center

Fellowship

  • Montefiore Hospital and Medical Center

Board Certifications

  • Medical Oncology
  • Hematology

Publications

Publications

  • Klute KA, Brouwer J, Jhawer M, et al. Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicenter analysis. Eur J Cancer. 2016 Aug;63:189-200
  • Shah MA, Jhawer M, Ilson D, Lekowitz RA et al. Phase II study of modified docetaxel, cisplatin,and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. J Clin Oncol 2011 Mar 1;29(7):868-74
  • Wilson AK, Cheuh AC, Togel L, Corner GA, Ahmed N, Goel S, Byun DS, Nasser S, Houston MA, Jhawer M et al. Apoptotic sensitivity of colon cancer cell lines to histone deacetylase inhibitors is mediated by sp1/sp3 activated transcriptional program involving immediate early gene induction. Cancer Res 2010 Jan 15; 70(2):609-20
  • Yuan Z, Shin J, Wilson A, Goel S, Ahmed N, Dopeso H, Jhawer M, et al. An A13 repeat within the 3-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression. Cancer Res 2009 Oct 1;69(19):7811-8
  • Jhawer M, Coit D, Brennan M, Qin L, Gonen M, Klimstra D, Tang L, Kelsen D, Shah MA. Perineural invasion following preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. Am J Clin Oncol. 2009 Aug;32(4):356-62
  • Jhawer M, Goel S, Wilson AJ, Montagna C, Ling YH et al. PIK3CA mutation/ PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res.2008 Mar 15;68(6):1953-61
  • Jhawer M, Kelsen D, Shah M. Incorporation of biologic therapies in the management of gastroesophageal cancers. Gastrointest Cancer Res. 2007 Mar; 1(2 suppl): S22-9
  • Jhawer M, Rosen L, Dancey J, Hochster H, Hamburg S, Tempero M, et al. Phase II Trial of Nolatrexed Dihydrochloride [ThymitaqTM, AG 337] in Patients with Advanced Hepatocellular Carcinoma. Investigational New Drugs 2007 Feb 25(1):85-94
  • Jhawer M, Mani S, Lefkopoulou M, Hahn R, Harris J, et al. Phase II study of Mitomycin-C, Adriamycin, Cisplatin and Bleomycin-CCNU in patients with advanced anal canal cancer: An ECOG study, E 7282. Investigational New Drugs 2006 Sep; 24(5):447-54
  • Goel S, Jhawer M, Sparano J, Mani S, et al Phase I clinical trial of the combination of irinotecan and oral capecitabine in patients with solid malignancies. Am J Clin Oncol. 2002 Oct; 25(5):528-34

For a full listing of Dr. Jhawer's publications, please visit PubMed.gov